CTI BioPharma Corp. (CTIC)

CTI BioPharma Revenue

CTI BioPharma had revenue of $75.77M in the twelve months ending March 31, 2023, with 3,201.48% growth year-over-year. Revenue in the quarter ending March 31, 2023 was $24.12M with 950.81% year-over-year growth. In the year 2022, CTI BioPharma had annual revenue of $53.95M.

• Revenue (ttm): $75.77M
• Revenue Growth: +3,201.48%
• P/S Ratio: 15.82
• Revenue / Employee: $596,606
• Employees: 127
• Market Cap: 1.20B USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2022	53.95M	-	-
Dec 31, 2021	0	-	-
Dec 31, 2020	0	-	-
Dec 31, 2019	3.35M	-22.95M	-87.28%
Dec 31, 2018	26.29M	1.14M	4.55%
Dec 31, 2017	25.15M	-32.26M	-56.20%
Dec 31, 2016	57.41M	41.29M	256.20%
Dec 31, 2015	16.12M	-43.96M	-73.17%
Dec 31, 2014	60.08M	25.40M	73.24%
Dec 31, 2013	34.68M	-	-
Dec 31, 2012	0	-	-
Dec 31, 2011	0	-	-
Dec 31, 2010	319.00K	239.00K	298.75%
Dec 31, 2009	80.00K	-11.35M	-99.30%
Dec 31, 2008	11.43M	11.31M	8,901.57%
Dec 31, 2007	127.00K	47.00K	58.75%
Dec 31, 2006	80.00K	-16.01M	-99.50%
Dec 31, 2005	16.09M	-13.50M	-45.62%
Dec 31, 2004	29.59M	4.83M	19.50%
Dec 31, 2003	24.77M	7.87M	46.57%
Dec 31, 2002	16.90M	10.66M	170.94%
Dec 31, 2001	6.24M	5.73M	1,142.23%
Dec 31, 2000	502.00K	-	-
Dec 31, 1999	0	-	-
Dec 31, 1998	13.20M	1.37M	11.57%
Dec 31, 1997	11.83M	2.71M	29.72%
Dec 31, 1996	9.12M	9.02M	9,020.81%
Dec 31, 1995	100.00K	-	-
Dec 31, 1994	0	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.